ATLANTA, Oct. 2, 2017 /PRNewswire/ -- CryoLife,
Inc. (NYSE: CRY), a leading medical device and tissue
processing company focused on cardiac and vascular surgery,
announced the appointment of Jeffrey H.
Burbank to its Board of Directors effective September 29, 2017.
Pat Mackin, Chairman, President,
and Chief Executive Officer, commented, "Jeff has over 30 years of
in-depth management experience in medical devices, highlighted by
his tenure growing NxStage Medical from inception to more than
$360 million in annual revenue. His
experience will allow him to bring a unique perspective to our
Board on our internal and external development programs. Jeff
brings a proven track record of success to the Board as we continue
to focus on accelerating the Company's growth."
Mr. Burbank said, "I am excited to join the CryoLife Board of
Directors. I share the Company's vision to advance the
standard of care with innovative products that help improve the
health and quality of life of patients. I look forward to working
with Pat, the Board and the CryoLife team as they continue to
advance the Company's mission."
Mr. Burbank is the Chief Executive Officer and founder of
NxStage Medical, Inc., (NASDAQ: NXTM) a leading medical technology
company that develops, manufactures and markets innovative products
for the treatment of end-stage renal disease (ESRD) and acute
kidney failure. Mr. Burbank has led NxStage since its
inception in 1998, guiding it through all of its developmental
phases to the successful initiation and rapid growth of commercial
activities, its initial public offering, the evolution of its
product line, its expansion into other markets, and its pending
acquisition by Fresenius Medical Care. Prior to NxStage, Mr.
Burbank was Chairman and Chief Executive Officer of Vasca, Inc., a
privately held, medical device company. Mr. Burbank previously
held leadership positions at ZymeQuest, Inc., and Gambro, Inc. Mr.
Burbank received his Bachelor of Science in Industrial Engineering
from Lehigh University.
About CryoLife, Inc.
Headquartered in suburban Atlanta,
Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of implantable living tissues and
medical devices used in cardiac and vascular surgical procedures.
CryoLife markets and sells products in more than 80 countries
worldwide. For additional information about CryoLife, visit our
website, www.cryolife.com.
Contacts:
CryoLife
D. Ashley
Lee
Executive Vice
President, Chief Financial Officer and Chief Operating
Officer
Phone:
770-419-3355
|
The Ruth
Group
Zack Kubow
646-536-7020
zkubow@theruthgroup.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/jeffrey-h-burbank-joins-cryolife-board-of-directors-300528709.html
SOURCE CryoLife, Inc.